Reach Neuro develops implantable spinal cord stimulation systems designed to restore voluntary upper-limb movement in people with chronic stroke. The company’s platform, Avantis, focuses on modulating spinal circuits involved in motor control rather than directly interfacing with the brain. Its approach aims to re-enable dormant motor pathways through targeted neuromodulation. Reach Neuro positions its technology within regulated clinical and rehabilitative care contexts.

The technology delivers electrical stimulation to specific regions of the cervical spinal cord to enhance excitability of motor circuits controlling the arms and hands. By pairing stimulation with rehabilitation and voluntary movement attempts, the system aims to facilitate functional recovery through activity-dependent plasticity. The implant is designed for chronic use, with stimulation parameters adjustable to individual patient needs. This approach emphasizes restoration of natural movement rather than compensatory assistive control.

Reach Neuro targets chronic stroke survivors who experience persistent upper-limb impairment despite conventional rehabilitation. The Avantis system is intended for use in specialized clinical settings under professional supervision. Its positioning reflects broader efforts to use spinal neuromodulation to restore motor function by leveraging preserved neural pathways below the site of brain injury.